Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher Thomas Appleton has a total of 419 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute TGFα drives OA-associated transcriptional and metabolic remodelling in primary chondrocytes

    by Emily L. White, Emily A. Day, C. Thomas Appleton, Matthew W. Grol, Frank Beier

  • Top Cited Papers
    Open Access

    Large-scale molecular endotype discovery in synovial fluid reveals osteoarthritis as a single biological continuum

    by T. A. Perry, Y. Deng, P. A. Hulley, R. A. Maciewicz, S. Larsson, J. Gogain, A. Struglics, C. T. Appleton, S. Kluzek, N. K. Arden, et al.

    Knee osteoarthritis affects 40% of people during their lifetime, significantly impacting societies worldwide. Its molecular pathogenesis remains poorly understood and variable clinical phenotypes suggest it may be more than one disease. We established S ynovial fluid T o detect E ndoty p es by U nbiased P roteomics in OA (STEpUP OA) to search for molecular endotypes in knee OA synovial fluid, and to reveal key pathobiological pathways across 1361 individuals with knee OA. Using unsupervised clustering, a single cluster representing a biological continuum is observed, primarily driven by “Epithelial Mesenchymal Transition”. Distinct molecular endotypes are not detected. “Angiogenesis”, “Complement” and “Coagulation” are enriched for after stratification by clinical phenotype (obesity status, biological sex). Complement and coagulation are associated with the inflammatory marker, C-reactive protein. Associations with patient-reported knee pain are weaker. These findings support knee OA as a biological continuum, identify common and phenotype-enriched targetable pathways, and a rationale for stratification in clinical trial design.


  • Open Access

    Metabolic syndrome and knee osteoarthritis: associations with disease stage and pain

    by Jami Kronick, Trevor B Birmingham, Surim Son, Andrew J E Appleton, C Thomas Appleton

    Objectives: Metabolic Syndrome (MetS) is associated with OA progression and pain. However, its relationship with outcomes in early-stage disease remains unclear. We assessed associations of MetS with radiographic stage and knee pain in individuals with symptomatic knee OA. Methods: We analysed cross-sectional baseline data from 251 participants in the Western Ontario Registry for Early Osteoarthritis (WOREO) Knee Study. Associations between MetS and radiographic stage were assessed using modified Poisson regression. Associations with knee pain, measured by the Knee Injury and Osteoarthritis Outcome Score (KOOS) pain scale, were evaluated using multiple linear regression accounting for within-participant correlation. Analyses were stratified by OA stage and adjusted for body mass index (BMI). Results: MetS was associated with a higher prevalence of late-stage knee OA [adjusted prevalence ratio 1.45 (95% CI 1.16, 1.81)]. After BMI adjustment, hypertension and haemoglobin A1c remained associated with late-stage disease. Participants with MetS reported worse knee pain, with lower KOOS pain scores [β = −14.70 (95% CI −20.92, −8.47)], particularly in early-stage disease [β = −14.15 (95% CI −20.37, −7.93)]. Dyslipidaemia (elevated triglycerides and reduced high-density lipoprotein cholesterol were also associated with worse pain in early-stage disease. Conclusion: MetS and its components are associated with greater radiographic severity and clinically meaningful worsening of pain, especially in early-stage knee OA, independent of BMI. These findings suggest that early identification and management of metabolic disease may represent a modifiable target to improve OA outcomes.


  • Exploring the association between adiposity, pain intensity, and effusion-synovitis in people with knee osteoarthritis: A cross-sectional study

    by Yv Raghava Neelapala, C Thomas Appleton, Luciana Macedo, Steve Hanna, Dylan Kobsar, Trevor B Birmingham, Lisa C. Carlesso

  • Tribute to Dr. Frank Beier (1965–2025)

    by Cheryle A. Séguin, C. Thomas Appleton

  • Open Access

    Fibroblast and myeloid cells with high mitochondrial RNA content represent biologically significant populations within the OA synovium

    by Wesley Tran, Garth Blackler, Rebecca Luo, C. Thomas Appleton, Matthew W. Grol


  • Open Access

    Evaluating Implementation Context to Prepare for Scaling Up the Integration of Interdisciplinary Healthcare Providers in Rheumatology Practices: A Rheumatology Workforce Survey

    by Jessica Widdifield, Celia Laur, Timothy S.H. Kwok, Laura Oliva, C. Thomas Appleton, Vandana Ahluwalia, J. Carter Thorne, Jenna C. Wong, Nicolas S. Bodmer, Molly J. Gomes, et al.

    Objective: Interdisciplinary healthcare providers (IHPs) can support effective delivery of optimal rheumatology care. To inform widespread implementation efforts, we assessed rheumatology workforce characteristics and determinants of integrating of IHPs within rheumatology practices in Ontario, Canada. Methods: A convergent mixed methods design included an environmental scan to identify clinically active rheumatologists and a workforce survey guided by the Consolidated Framework for Implementation Research (CFIR) 2.0. Quantitative data were analyzed descriptively and stratified by subgroups. Qualitative responses were analyzed using conventional content analysis. Integration of findings enabled a comprehensive understanding of implementation determinants. Results: Of the 293 Ontario rheumatologists identified by the environmental scan (as of 2025), 26 were nearing retirement, leaving potentially 267 eligible for the survey. One hundred ninety-seven rheumatologists participated in the survey, yielding a response rate of 74% and coverage of > 90% of practice sites. Pediatric rheumatologists and those in hospital-based settings had more structural and collaborative supports than community-based rheumatologists. Overall, 177 (91%) indicated they were interested in adding IHPs, with 126 (65%) preferring an extended role/scope provider. Although inadequate funding was the key deterrent to adoption, motivational readiness was high: 92% perceived an IHP team-based model as an improvement, 86% saw it as a good fit, and 83% considered it a priority to better meet patient needs. Many noted a lack of supportive climate, including that of resources and processes, to enable this practice change. Conclusion: Rheumatologists report high motivation for practice change to integrate IHPs. System- and practice-level implementation strategies are needed to support workforce transformation.

  • Open Access

    Immune checkpoint inhibitor associated vasculitis and polymyalgia rheumatica: a case series and systematic review

    by Aaron Teel, Adrian Grebowicz, Yuliya Lytvyn, Stephanie Garner, C. Thomas Appleton, Alexandra P. Saltman, Nader Khalidi, Mats Junek, Faiza Khokhar

    Immune checkpoint inhibitors (ICIs) have been associated with immune-related adverse events (irAEs), including ICI associated vasculitis (ICI-vasculitis) and ICI associated PMR (ICI-polymyalgia rheumatica (PMR)-like syndromes). We sought to describe the characteristics of ICI-vasculitis and ICI-PMR in individuals treated with ICIs through a systematic review and local case series. We searched MEDLINE and Embase from inception to July 2023 for cases of ICI-vasculitis and ICI-PMR in ICI-treated individuals. Our series included cases obtained from clinicians at the Universities of Toronto, McMaster, and Western in Ontario, Canada. One hundred and forty-four patients were identified: 130 from the systematic review in 76 articles and 14 from our case series. This included 73 patients with ICI-vasculitis (14 large vessel, 7 ANCA-associated, 52 other) and 71 with ICI-PMR. Ninety-five per cent of patients were treated with glucocorticoids and 17% received disease-modifying antirheumatic drugs (DMARDs). Among 4 individuals with vasculitis who continued the ICI, two remitted. Of five who paused and restarted ICIs, one experienced a recurrence. Among four individuals with vasculitis who continued ICIs, two remitted. All 11 ICI-PMR cases that continued ICIs remitted; among 3 patients who paused and restarted two did not relapse and one had a relapse that improved with an increase in their dose of prednisone. ICI-vasculitis and ICI-PMR are underrecognized complications of ICIs. Glucocorticoids are effective for ICI-vasculitis and ICI-PMR. It is unclear if ICIs can be safely continued or restarted after remission of ICI-vasculitis or ICI-PMR. Limited data suggests ICIs may be resumed in individuals with non-severe ICI-vasculitis or ICI-PMR.


  • Synovial joint organ homeostasis: mechanisms and biological considerations

    by Garth Blackler, Hanyu Jiang, C. Thomas Appleton

    Synovial joints are complex multi-tissue organs that permit movement. A well-functioning synovial joint relies on complex interconnected homeostatic mechanisms to maintain joint organ function in response to biomechanical and metabolic demands. These homeostatic mechanisms include, but are not limited to, appropriate mechanobiological responses to load, nutrient delivery from its vasculature, lubrication, proprioception and pain, immunosurveillance, and maintenance of the extracellular matrix (ECM) composition. In osteoarthritis (OA), joint homeostasis is chronically deranged leading to failure of the synovial joint organ and impairment or loss of function. Maintaining synovial joint organ homeostasis is therefore critical to joint function and relies on complex interconnected physiological process at the joint level. As OA prevalence continues to rise, deepening our understanding of the integrated systems that sustain joint homeostasis may identify fruitful avenues for therapeutic intervention. However, key knowledge gaps will need to be addressed including, characterizing vessel function in joint diseases, understanding the role of novel proteases in ECM catabolism, and determining the role of non-macrophage synovial immune cells in joint immunosurveillance. We believe that future research will find greater success if these homeostatic mechanisms are viewed as a single integrated system that considers the crosstalk between mechanical, vascular, immune, and biochemical factors. Therefore, in this review, we explore the interconnected mechanisms that support joint homeostasis and how dysregulation can lead to failure of the synovial joint organ.


  • Open Access

    Elucidating the initial symptoms and experiences of knee osteoarthritis: An international patient survey

    by Lauren K. King, Armaghan Mahmoudian, Jean W. Liew, Qiuke Wang, Ian Stanaitis, Dieuwke Schiphof, Leigh F. Callahan, David J. Hunter, C. Thomas Appleton, Aleksandra Turkiewicz, et al.